NATCO PHARMA LTD. (NATCOPHARM)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 897.90 1,140.50 1,031.40 758.60 1,068.30 1,362.60 1,371.10 474.80 1,221.00 1,328.90 1,363.00 647.30
YOY Revenue Growth % 50.45% 28.93% 138.69% 54.03% 18.98% 19.47% 32.94% -37.41% 14.29% -2.47% -0.59% 36.33%
Other Income 29.00 19.70 29.40 37.00 42.00 48.10 63.80 176.30 66.30 61.70 100.00 58.10
Total Income 926.90 1,160.20 1,060.80 795.60 1,110.30 1,410.70 1,434.90 651.10 1,287.30 1,390.60 1,463.00 705.40
Total Expenses + 446.70 552.70 524.10 420.50 556.00 528.90 532.40 425.90 781.40 818.70 849.30 544.30
Cost of Materials Consumed 146.30 136.20 166.50 92.20 127.60 151.30 143.20 72.70 169.00 180.60 174.90 135.20
Employee Benefit Expense 118.90 138.20 122.40 121.90 142.50 142.00 151.50 141.60 159.40 169.00 200.30 159.40
Other Expenses 181.50 278.30 235.20 206.40 285.90 235.60 237.70 211.60 264.30 355.90 413.80 196.10
Operating Profit 451.20 587.80 507.30 338.10 512.30 833.70 838.70 48.90 439.60 510.20 513.70 103.00
OPM % 50.3% 51.5% 49.2% 44.6% 48% 61.2% 61.2% 10.3% 36% 38.4% 37.7% 15.9%
Profit Before Tax + 324.40 500.00 439.60 256.30 477.60 803.60 818.20 163.70 505.90 571.90 613.70 161.10
Tax Expense 48.60 79.70 70.60 43.60 91.30 135.10 141.70 31.30 99.90 91.60 95.80 9.80
Tax % 15% 15.9% 16.1% 17% 19.1% 16.8% 17.3% 19.1% 19.7% 16% 15.6% 6.1%
Profit After Tax 275.80 420.30 369.00 212.70 386.30 668.50 676.50 132.40 406.00 480.30 517.90 151.30
EPS (Basic) 15.11 23.26 20.60 11.88 21.56 37.32 37.81 7.43 22.70 26.84 28.94 8.46

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 4,429.50 3,998.80 2,707.10 1,944.80 2,052.10 1,915.00 2,094.50
YOY Revenue Growth % 10.77% 47.72% 39.2% -5.23% 7.16% -8.57% -
Other Income 354.50 128.10 104.60 99.00 103.60 107.40 130.20
Total Income 4,784.00 4,126.90 2,811.70 2,043.80 2,155.70 2,022.40 2,224.70
Total Expenses + 2,492.60 2,053.30 1,619.50 1,639.60 1,307.40 1,279.80 1,278.60
Cost of Materials Consumed 536.20 522.50 475.30 519.20 372.90 329.00 333.10
Employee Benefit Expense 594.50 525.00 486.70 444.80 414.90 375.00 355.90
Other Expenses 949.20 1,005.80 657.50 675.60 519.60 575.80 589.60
Operating Profit 1,936.90 1,945.50 1,087.60 305.20 744.70 635.20 815.90
OPM % 43.7% 48.7% 40.2% 15.7% 36.3% 33.2% 39%
Profit Before Exceptional 2,291.40 1,673.50 861.90 202.20 579.60 568.70 824.70
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 2,291.40 1,673.50 861.90 202.20 579.60 568.70 824.70
Tax Expense 408.00 285.20 146.60 32.20 137.20 110.60 182.30
Tax % 17.8% 17% 17% 15.9% 23.7% 19.4% 22.1%
Profit After Tax 1,883.40 1,388.30 715.30 170.00 442.40 458.10 642.40
EPS (Basic) 105.26 77.34 39.18 9.32 24.20 25.33 34.98

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 3,360.80 2,882.80 2,657.10 0.00 0.00 0.00 0.00
Property, Plant & Equipment 2,431.90 2,297.70 2,239.10 0.00 0.00 0.00 0.00
Capital Work in Progress 225.40 137.30 64.30 0.00 0.00 0.00 0.00
Non-Current Investments 152.80 95.90 87.30 0.00 0.00 0.00 0.00
Goodwill 57.40 56.00 55.20 0.00 0.00 0.00 0.00
Other Intangible Assets 208.70 137.10 132.60 0.00 0.00 0.00 0.00
Current Assets + 5,270.00 4,023.50 3,000.30 0.00 0.00 0.00 0.00
Inventories 765.80 700.50 742.90 0.00 0.00 0.00 0.00
Trade Receivables 1,246.60 1,188.90 856.10 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 120.00 70.40 131.90 0.00 0.00 0.00 0.00
Current Investments 320.80 443.50 305.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 35.80 35.80 36.50 0.00 0.00 0.00 0.00
Other Equity 7,571.20 5,817.30 4,837.30 0.00 0.00 0.00 0.00
Non-Current Liabilities 75.00 80.40 100.50 0.00 0.00 0.00 0.00
Current Liabilities 943.50 972.80 683.10 0.00 0.00 0.00 0.00
Total Liabilities 1,018.50 1,053.20 783.60 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 1,696.80 1,211.60 849.10 46.50 0.00 0.00 0.00
Cash from Investing Activities -1,414.50 -1,032.70 -477.10 -5.30 0.00 0.00 0.00
Cash from Financing Activities -210.70 -246.90 -363.00 34.80 0.00 0.00 0.00
Net Increase/Decrease in Cash 49.60 -61.50 20.80 85.30 0.00 0.00 0.00